{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:08:00Z","timestamp":1791176880410,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T00:00:00Z","timestamp":1357603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-10","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T01:28:53Z","timestamp":1357694933000},"source":"Crossref","is-referenced-by-count":61,"title":["Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe"],"prefix":"10.1186","volume":"13","author":[{"given":"R\u00e9mi","family":"Marty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Roze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Largeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Smith-Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,8]]},"reference":[{"key":"3632_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2407-12-30","volume":"12","author":"S Hartwig","year":"2012","unstructured":"Hartwig S, Syrj\u00e4nen S, Dominiak-Felden G, Brotons M, Castellsague X: Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer. 2012, 12: 30-10.1186\/1471-2407-12-30.","journal-title":"BMC Cancer"},{"key":"3632_CR2","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/ijc.24116","volume":"124","author":"H De Vuyst","year":"2009","unstructured":"De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S: Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009, 124: 1626-36. 10.1002\/ijc.24116.","journal-title":"Int J Cancer"},{"key":"3632_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1758-3284-2-15","volume":"2","author":"F Dayyani","year":"2010","unstructured":"Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS: Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010, 2: 15-10.1186\/1758-3284-2-15.","journal-title":"Head Neck Oncol"},{"key":"3632_CR4","first-page":"870","volume":"62","author":"C Miralles-Guri","year":"2009","unstructured":"Miralles-Guri C, Bruni L, Cubilla AL, Castellsagu\u00e9 X, Bosch FX, de Sanjos\u00e9 S: Human papillomavirus prevalence and type distribution in penile carcinoma. J ClinPathol. 2009, 62: 870-8.","journal-title":"J ClinPathol"},{"key":"3632_CR5","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1016\/j.vaccine.2011.05.018","volume":"29","author":"I Borget","year":"2011","unstructured":"Borget I, Abramowitz L, Mathevet P: Economic burden of HPV-related cancers in France. Vaccine. 2011, 29: 5245-9. 10.1016\/j.vaccine.2011.05.018.","journal-title":"Vaccine"},{"key":"3632_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/sj.bjc.6604871","volume":"100","author":"D Robinson","year":"2009","unstructured":"Robinson D, Coupland V, M\u00f8ller H: An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer. 2009, 100: 527-31. 10.1038\/sj.bjc.6604871.","journal-title":"Br J Cancer"},{"key":"3632_CR7","doi-asserted-by":"publisher","first-page":"c1439","DOI":"10.1136\/bmj.c1439","volume":"340","author":"H Mehanna","year":"2010","unstructured":"Mehanna H, Jones TM, Gregoire V, Ang KK: Oropharyngeal carcinoma related to human papillomavirus. BMJ. 2010, 340: c1439-10.1136\/bmj.c1439.","journal-title":"BMJ"},{"key":"3632_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ijc.24339","volume":"125","author":"A Nasman","year":"2009","unstructured":"Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Spar\u00e9n P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T: Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer. 2009, 125: 362-366. 10.1002\/ijc.24339.","journal-title":"Int J Cancer"},{"key":"3632_CR9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.olq.0000253337.62932.29","volume":"34","author":"AF Dempsey","year":"2007","unstructured":"Dempsey AF, Koutsky LA, Golden M: Potential impact of human papillomavirus vaccines on public STD clinic workloads and on opportunities to diagnose and treat other sexually transmitted diseases. Sex Transm Dis. 2007, 34: 503-7.","journal-title":"Sex Transm Dis"},{"key":"3632_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","volume":"11","author":"B Donovan","year":"2011","unstructured":"Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK: Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis. 2011, 11: 39-44. 10.1016\/S1473-3099(10)70225-5.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 3","key":"3632_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.vaccine.2006.06.015","volume":"24","author":"CJ Lacey","year":"2006","unstructured":"Lacey CJ, Lowndes CM, Shah KV: Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease. Vaccine. 2006, 24 (Suppl 3): 35-41.","journal-title":"Vaccine"},{"key":"3632_CR12","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1185\/03007990903136378","volume":"25","author":"T Hoy","year":"2009","unstructured":"Hoy T, Singhal PK, Willey VJ, Insinga RP: Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Curr Med Res Opin. 2009, 25: 2343-51. 10.1185\/03007990903136378.","journal-title":"Curr Med Res Opin"},{"key":"3632_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.gyobfe.2006.12.010","volume":"35","author":"J Monson\u00e9go","year":"2007","unstructured":"Monson\u00e9go J, Breugelmans JG, Bou\u00e9e S, Lafuma A, B\u00e9nard S, R\u00e9my V: Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France. Gynecol Obstet Fertil. 2007, 35: 107-13. 10.1016\/j.gyobfe.2006.12.010.","journal-title":"Gynecol Obstet Fertil"},{"key":"3632_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11591170-000000000-00000","volume":"30","author":"AJ Raymakers","year":"2012","unstructured":"Raymakers AJ, Sadatsafavi M, Marra F, Marra CA: Economic and humanistic burden of external genital warts. PharmacoEconomics. 2012, 30: 1-16. 10.2165\/11591170-000000000-00000.","journal-title":"PharmacoEconomics"},{"issue":"1","key":"3632_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/eurpub\/ckn127","volume":"19","author":"X Castellsagu\u00e9","year":"2009","unstructured":"Castellsagu\u00e9 X, Cohet C, Puig-Tintor\u00e9 LM, Acebes LO, Salinas J, San Martin M, Breitscheidel L, R\u00e9my V: Epidemiology and cost of treatment of genital warts in Spain. Eur J Public Health. 2009, 19 (1): 106-10.","journal-title":"Eur J Public Health"},{"key":"3632_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D: Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. New Engl J Med. 2011, 364: 401-11. 10.1056\/NEJMoa0909537.","journal-title":"New Engl J Med"},{"key":"3632_CR17","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1016\/j.vaccine.2010.08.030","volume":"28","author":"EH Elbasha","year":"2010","unstructured":"Elbasha EH, Dasbach EJ: Impact of vaccinating boys and men against HPV in the United States. Vaccine. 2010, 28: 6858-67. 10.1016\/j.vaccine.2010.08.030.","journal-title":"Vaccine"},{"key":"3632_CR18","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.1016\/j.vaccine.2011.02.091","volume":"29","author":"MA Smith","year":"2011","unstructured":"Smith MA, Lew JB, Walker RJ, Brotherton JM, Nickson C, Canfell K: The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. Vaccine. 2011, 29: 9112-22. 10.1016\/j.vaccine.2011.02.091.","journal-title":"Vaccine"},{"key":"3632_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/infdis\/jir285","volume":"204","author":"M Brisson","year":"2011","unstructured":"Brisson M, van de Velde N, Franco EL, Drolet M, Boily MC: Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. J Infect Dis. 2011, 204: 372-6. 10.1093\/infdis\/jir285.","journal-title":"J Infect Dis"},{"issue":"Suppl","key":"3632_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4161\/hv.7.0.14575","volume":"7","author":"P Bonanni","year":"2011","unstructured":"Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, Panatto D, Gasparini R, Boccalini S: An overview on the implementation of HPV vaccination in Europe. Hum Vaccin. 2011, 7 (Suppl): 128-35.","journal-title":"Hum Vaccin"},{"issue":"12","key":"3632_CR21","doi-asserted-by":"publisher","first-page":"e1001147","DOI":"10.1371\/journal.pmed.1001147","volume":"8","author":"JA Bogaards","year":"2011","unstructured":"Bogaards JA, Kretzschmar M, Xiridou M, Meijer CJ, Berkhof J, Wallinga J: Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models. PLoS Med. 2011, 8 (12): e1001147-10.1371\/journal.pmed.1001147.","journal-title":"PLoS Med"},{"key":"3632_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3201\/eid1301.060438","volume":"13","author":"EH Elbasha","year":"2007","unstructured":"Elbasha EH, Dasbach EJ, Insinga RP: Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007, 13: 28-41. 10.3201\/eid1301.060438.","journal-title":"Emerg Infect Dis"},{"key":"3632_CR23","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1471-0528.2008.01743.x","volume":"115","author":"EJ Dasbach","year":"2008","unstructured":"Dasbach EJ, Insinga RP, Elbasha EH: The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6\/11\/16\/18) in the UK. BJOG. 2008, 115: 947-56. 10.1111\/j.1471-0528.2008.01743.x.","journal-title":"BJOG"},{"key":"3632_CR24","doi-asserted-by":"publisher","first-page":"d5775","DOI":"10.1136\/bmj.d5775","volume":"343","author":"M Jit","year":"2011","unstructured":"Jit M, Chapman R, Hughes O, Choi YH: Comparing bivalent and quadrivalent humanpapillomavirus vaccines: economic evaluation based on transmission model. BMJ. 2011, 343: d5775-10.1136\/bmj.d5775.","journal-title":"BMJ"},{"key":"3632_CR25","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/j.ejca.2009.07.017","volume":"45","author":"A Anttila","year":"2009","unstructured":"Anttila A, Ronco G, Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE): Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer. 2009, 45: 2685-708. 10.1016\/j.ejca.2009.07.017.","journal-title":"Eur J Cancer"},{"key":"3632_CR26","doi-asserted-by":"publisher","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","volume":"29","author":"HW Chesson","year":"2011","unstructured":"Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE: The cost-effectiveness of male HPV vaccination in the United States. Vaccine. 2011, 29: 8443-50. 10.1016\/j.vaccine.2011.07.096.","journal-title":"Vaccine"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-10\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T02:15:58Z","timestamp":1595211358000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,8]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3632"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-10","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,8]]},"article-number":"10"}}